课题基金 / 基金详情

ANTIOXIDANT EFFECTS OF CARVEDILOL IN HYPERTENSIVE, CHRONIC SMOKERS

ANTIOXIDANT EFFECTS OF CARVEDILOL IN HYPERTENSIVE, CHRONIC SMOKERS
卡维地洛对高血压、长期吸烟者的抗氧化作用
批准号:
6244490
负责人:
GARRET A FITZGERALD
金额:
$2.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-17 至 1998-02-28

项目摘要

项目成果

GARRET A FITZGERALD的其他基金

相似基金

相关文献

中文摘要
翻译
这项研究是在患者中进行的,以确定卡维地洛是否有
英文摘要
This study is being conducted in patients to determine if carvedilol has properties similar to those of an antioxidant. Antioxidants consist of drugs and vitamins that prevent or correct certain chemical reactions from occuring in the body. Such reactions may be harmful so that their prevention by an antioxidant may be beneficial. The objectives of this study is to explore the antioxidant effects of carvedilol following single and repeat oral dosing at two dose levels as compared to dosing with an antioxidant control (Vitamins C and E) and a hypotensive control (hydrochlorothiazide) in hypertensive, chronic smokers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Institutional Clinical and Translational Sciences Award
  • 批准号:
    10487653
  • 项目类别:
  • 资助金额:
    $6.13万
  • 财政年份:
    2022
  • 负责人:
    GARRET A FITZGERALD
  • 依托单位:
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade
  • 批准号:
    10304145
  • 项目类别:
  • 资助金额:
    $65.41万
  • 财政年份:
    2019
  • 负责人:
    GARRET A FITZGERALD
  • 依托单位:
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade
  • 批准号:
    10065018
  • 项目类别:
  • 资助金额:
    $66.99万
  • 财政年份:
    2019
  • 负责人:
    GARRET A FITZGERALD
  • 依托单位:
Institutional Clinical and Translational Science Award
  • 批准号:
    10348879
  • 项目类别:
  • 资助金额:
    $1016.45万
  • 财政年份:
    2016
  • 负责人:
    GARRET A FITZGERALD
  • 依托单位:
海外基金